Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
D000818:Animals; D001215:Asparaginase / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D002296:Carcinosarcoma / Q000188:drug therapy; D004285:Dogs; D004926:Escherichia coli / Q000032:analysis; D006168:Guinea Pigs; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008025:Ligases / Q000378:metabolism; D008223:Lymphoma / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000201:enzymology; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D014633:Valine / Q000378:metabolism
D014316:Tritium; D001215:Asparaginase; D008025:Ligases; D014633:Valine; D014529:Uridine